Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy

QR Code

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy

© 2015 by the Society for Experimental Biology and Medicine Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to selectively induce apoptotic cell death in various tumor cells by engaging its death-inducing receptors (TRAIL-R1 and TRAIL-R2). This property has led to the...

Full description

Bibliographic Details
Main Authors:	Dai, X., Zhang, J., Arfuso, Frank, Chinnathambi, A., Zayed, M., Alharbi, S., Kumar, A., Ahn, K., Sethi, G.
Format:	Journal Article
Published:	SAGE Publications Inc. 2015
Online Access:	http://hdl.handle.net/20.500.11937/5659

Similar Items

Synergistic anticancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL) and doxorubicin using micellar polymer nanoparticles
by: Lee, A., et al.
Published: (2012)

Oleuropein induces apoptosis via abrogating NF-?B activation cascade in estrogen receptor–negative breast cancer cells
by: Liu, L., et al.
Published: (2018)

NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)

Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles
by: Lee, A., et al.
Published: (2011)

An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins
by: Subramaniam, Aruljothi, et al.
Published: (2013)

Zebularine and trichostatin a sensitized human breast adenocarcinoma cells towards tumour necrosis-factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
by: Kong, Wei Yang
Published: (2019)

Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
by: Kong, Wei Yang, et al.
Published: (2019)

Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)

Tumor necrosis factor receptor I blockade shows that TNF-dependent and independent mechanisms synergise in TNF receptor associated periodic syndrome
by: Fairclough, Lucy C., et al.
Published: (2015)

Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour
by: Fakiruddin, Kamal Shaik, et al.
Published: (2018)

The future of osteoarthritis therapeutics: targeted pharmacological therapy
by: Mobasheri, Ali
Published: (2013)

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer
by: Banik, K., et al.
Published: (2018)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS)
by: Negm, Ola H., et al.
Published: (2014)

Molecular targets modulated by fangchinoline in tumor cells and preclinical models
by: Mérarchi, M., et al.
Published: (2018)

Synthesis, biological evaluation, and utility of fluorescent ligands targeting the μ-opioid receptor
by: Schembri, Luke S., et al.
Published: (2015)

Trichostrongylus colubriformis extract upregulates TNF-α receptor expression and enhances TNF-α sensitivity of L929 cells
by: Riffkin, M.C., et al.
Published: (2000)

Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis
by: Ashour, Abdelkader Elbadawy Abbas, et al.
Published: (2014)

Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-?B signaling cascade in gastric cancer
by: Manu, K., et al.
Published: (2015)

Cancer and apoptosis: the apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics
by: Chaudhry, Gul-e-Saba, et al.
Published: (2022)

The TRAIL to cancer therapy: hindrances and potential solutions
by: Wong, Sonia How Ming, et al.
Published: (2019)

The effect of ovarian reserve and receptor signalling on granulosa cell apoptosis during human follicle development
by: Regan, S., et al.
Published: (2017)

Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis
by: Treude, Fabian, et al.
Published: (2014)

The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)

The multifaceted role of curcumin in cancer prevention and treatment
by: Shanmugam, M., et al.
Published: (2015)

SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)

A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2017)

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)

Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
by: Zhang, J., et al.
Published: (2017)

N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-kB signaling pathway
by: Mohan, C., et al.
Published: (2018)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

NanoBRET to probe ligand-receptor and receptor-receptor interactions in living cells
by: Carvalheira Alcobia, Diana
Published: (2019)

Therapeutic targeting of the leukaemia microenvironment
by: Kuek, V., et al.
Published: (2021)

NADPH oxidase mediates TNF-α-evoked in vitro brain barrier dysfunction: roles of apoptosis and time
by: Abdullah, Zuraidah, et al.
Published: (2014)

Tumor Necrosis factor–Nelated Apoptosis‐Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia‐Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide–Dependent Mechanisms
by: Di Bartolo, Belinda Ann, et al.
Published: (2015)

Computational modelling of LY303511 and TRAIL-induced apoptosis suggests dynamic regulation of cFLIP
by: Shi, Y., et al.
Published: (2013)

Therapeutic targeting of p53-mediated apoptosis pathway in head and neck squamous cell carcinomas: current progress and challenges
by: Arief Ichwan, Solachuddin Jauhari, et al.
Published: (2012)

New therapeutic targets for osteoarthritis pain
by: Walsh, David A., et al.
Published: (2017)

Characterisation of TNF block haplotypes affecting the production of TNF and LTA
by: Tan, J., et al.
Published: (2011)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t16hbddcfsqs8s30vvuc25h8qj